Molecular medicine is an emerging field of healthcare that has the power to improve the lives of patients with life-threatening diseases. Molecular medicine targets disease at the molecular level to advance patient care through timely and accurate detection, improved treatment and effective monitoring of therapeutic response and disease progression.
Advances in molecular biology and the growing understanding of the biochemical and molecular basis of disease at the cellular level are accelerating the discovery and development of new molecular medicines that target specific cells, proteins, sub-cellular structures and/or biochemical pathways.
Molecular Insight Pharmaceuticals is focusing on using proprietary drug discovery platform technology in the development of two types of targeted molecular radiopharmaceuticals: